Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:01 pm Sale | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | RA CAPITAL MANAGEMENT L.P. | 48,600,221 9.99% | -79 (-0.00%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | INHIBRX INC INBX | RA CAPITAL MANAGEMENT L.P. | 4,724,352 9.99% | 870,485 (+22.59%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | MACROGENICS INC MGNX | RA CAPITAL MANAGEMENT L.P. | 4,053,077 6.5% | 288,206 (+7.66%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | RXSIGHT INC RXST | RA CAPITAL MANAGEMENT L.P. | 3,404,285 9.5% | 351,489 (+11.51%) | View |
| 2024-02-14 5:01 pm Sale | 13G | TAYSHA GENE THERAPIES INC TSHA | RA CAPITAL MANAGEMENT L.P. | 18,670,089 9.99% | -20,779 (-0.11%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | TENAYA THERAPEUTICS INC TNYA | RA CAPITAL MANAGEMENT L.P. | 6,948,236 9.99% | 519,753 (+8.09%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | VAXCYTE INC PCVX | RA CAPITAL MANAGEMENT L.P. | 9,685,079 9.99% | 1,531,520 (+18.78%) | View |
| 2024-02-14 5:01 pm Sale | 13G | VERONA PHARMA PLC SPONSORED AD VRNA | RA CAPITAL MANAGEMENT L.P. | 7,503,976 9.99% | -188,014 (-2.44%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | HARPOON THERAPEUTICS INC N HARP | RA CAPITAL MANAGEMENT L.P. | 1,712,792 9.99% | 11,222 (+0.66%) | View |
| 2024-02-14 5:01 pm Sale | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 1,286,960 5% | -962,461 (-42.79%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | APOGEE THERAPEUTICS INC APGE | RA CAPITAL MANAGEMENT L.P. | 1,977,901 5.3% | 1,977,901 (New Position) | View |
| 2024-02-14 5:01 pm Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,330,412 9% | -185,655 (-3.37%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | UROGEN PHARMA LTD URGN | RA CAPITAL MANAGEMENT L.P. | 3,083,558 9.99% | 8 (+0.00%) | View |
| 2024-02-14 5:01 pm Sale | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | RA CAPITAL MANAGEMENT L.P. | 8,197,333 9.9% | -1,136,000 (-12.17%) | View |
| 2024-02-14 5:01 pm Sale | 13G | HILLEVAX INC HLVX | RA CAPITAL MANAGEMENT L.P. | 0 0% | -1,760,019 (Position Closed) | View |
| 2024-02-14 5:01 pm Sale | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 0 0% | -5,999,481 (Position Closed) | View |
| 2024-02-14 5:01 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | RA CAPITAL MANAGEMENT L.P. | 0 0% | -4,398,453 (Position Closed) | View |
| 2024-02-14 5:01 pm Sale | 13G | NANOSTRING TECHNOLOGIES INC CO NSTG | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,577,373 (Position Closed) | View |
| 2024-02-13 4:16 pm Purchase | 13D | PEPGEN INC PEPG | RA CAPITAL MANAGEMENT L.P. | 10,695,135 34.1% | 2,563,183 (+31.52%) | View |
| 2024-02-12 4:49 pm Purchase | 13D | MINERALYS THERAPEUTICS INC MLYS | RA CAPITAL MANAGEMENT L.P. | 4,949,307 9.99% | 1,768,387 (+55.59%) | View |